Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double‐blind, placebo‐controlled trial

Hepatology

Volumn 12, Issue 4, 1990, Pages 716-724

  Ginés, Pere ^a   Rimola, Antoni ^a   Planas, Ramón ^b   Vargas, Victor ^c   Marco, Francesc ^a   Almela, Manuel ^a   Forne, Montserrat ^d,f   Miranda, Maria Luisa ^e   Llach, Josep ^a   Salmerón, Joan Manuel ^a   Esteve, Maria ^b   Marques, Josep Maria ^a   de Anta, Maria Teresa Jiménez ^a   Arroyo, Vicente ^a   Rodés, Joan ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b Hospital Germans Trias i Pujol of Badalona   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d Hospital de la Vall d'Hebró of Barcelona ^*  (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NORFLOXACIN; NYSTATIN;

ARTICLE; ASCITES; CANDIDA; CONTROLLED STUDY; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PERITONITIS; PRIORITY JOURNAL;

BACTERIAL INFECTIONS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FECES; FEMALE; HUMAN; LIVER CIRRHOSIS; MALE; MIDDLE AGE; NORFLOXACIN; PATIENT COMPLIANCE; PERITONITIS; RECURRENCE; SUPPORT, NON-U.S. GOV'T;

EID: 0025151559     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840120416     Document Type: Article

References (38)

1. Infecciones bacterianas en la cirrosis hepática
2. Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients
3. Montgomerie JZ. Spontaneous bacterial peritonitis
4. Les infections du liquide ascitique chez le cirrhotique: étude clinique et biologique de 36 épisodes observés au cours d'une année
5. The clinical value of ascitic fluid culture and leukocyte count studies in alcoholic cirrhosis
6. Cefotaxime is more effective than is ampicillintobramycin in cirrhotics with severe infections
7. Spontaneous bacterial peritonitis: an explosion of information
8. Polymorphonuclear cell count and duration of antibiotic therapy in spontaneous bacterial peritonitis
9. Spontaneous bacterial peritonitis
10. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors
11. Colonization resistance of the digestive tract: clinical consequences and implications
12. Bacteriological aspects of selective intestinal decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients
13. Infection prevention in granulocytopenic patients by selective decontamination of digestive tract
14. Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria
15. Oral nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage
16. Norfloxacin: a new targeted fluoroquinolone antimicrobial agent
17. Oral norfloxacin produces a selective bowel decontamination in cirrhotic patients. [Abstract]
18. Oral norfloxacin for prevention of gram‐negative bacterial infections in patients with acute leukemia and granulocytopenia: a randomized, double‐blind, placebo‐controlled trial
19. Norfloxacin for prevention of bacterial infections in granulocytopenic patients
20. Culture‐negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis
21. Estudio controlado de la eficacia terapéutica de pos pautas antibióticas en la peritonitis bacteriana espontánea de la cirrosis: valor pronóstico de los datos bacteriológicos
22. Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by highperformance liquid chromatography
23. Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with human faecal flora
24. Impact of imipenem/cilastatin therapy on normal fecal flora
25. Regression models and life tables
26. Norfloxacin for selective decontamination: a study in human volunteers
27. Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple‐dose pharmacokinetics
28. Lack of emergence of resistant fecal flora during successful prophylaxis of traveler's diarrhea with norfloxacin
29. Effects of norfloxacin of the faecal flora in patients with complicated urinary tract infections
30. In vitro antibacterial activity of norfloxacin (MK‐0366)
31. Spontaneous bacterial peritonitis in cirrhosis: variations on a theme
32. Spontaneous bacterial peritonitis in cirrhosis: endemic or epidemic?
33. Infección peritoneal en la cirrosis hepática con ascitis: cinco años de experiencia
34. Low‐protein concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis